Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
The Subventricular Zone is Able to Respond to a Demyelinating Lesion after Localized Radiation.
An updated role of microRNA-124 in central nervous system disorders: a review.
Pain and Cognition in Multiple Sclerosis.
Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.
Ipilimumab in patients with melanoma and autoimmune disease.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis.
Interferon Beta and Long-term Disability in Multiple Sclerosis-Reply.
Olfactory dysfunction in patients with neuromyelitis optica.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).]
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
The current role of mitoxantrone in the treatment of multiple sclerosis.
Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest.
Shift.ms.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Commentary.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
Fish and egg specific immunoglobin e in multiple sclerosis patients.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Autoantibodies to Glutamate Receptor Antigens in Multiple Sclerosis and Rasmussen's Encephalitis.
Pages
« first
‹ previous
…
542
543
544
545
546
547
548
549
550
…
next ›
last »